1-4 of 4
Ayse Kars, MD
Close
Save search
Sort by
Journal Articles

Rituximab in Combination with Cyclophosphamide, Mitoxantrone, Vincristine and Prednisone (R-CNOP) As First Line Regimen in Elderly Patients with Diffuse Large B-Cell Lymphoma

Free
Alma Aslan, MD, Alev Turker, MD, Ayse Kars, MD, Ibrahim Barista, MD, Evren Ozdemir, MD
Journal: Blood
Blood (2016) 128 (22): 5390.
https://doi.org/10.1182/blood.V128.22.5390.5390
Published: 2016
Journal Articles

Gemcitabine in Combination with Oxaliplatin (GEMOX) As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma

Free
Evren Ozdemir, MD, Alma Aslan, MD, Alev Turker, MD, Ibrahim Barista, MD, Ayse Kars, MD
Journal: Blood
Blood (2015) 126 (23): 1517.
https://doi.org/10.1182/blood.V126.23.1517.1517
Published: 2015
Journal Articles

Single Agent Gemcitabine As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma after Autologous Stem Cell Transplantation

Free
Evren Ozdemir, MD, Alma Aslan, MD, Alev Turker, MD, Ibrahim Barista, MD, Ayse Kars, MD
Journal: Blood
Blood (2015) 126 (23): 5090.
https://doi.org/10.1182/blood.V126.23.5090.5090
Published: 2015
Journal Articles

Bortezomib, Dexamethasone and Concomitant or Sequential Thalidomide (VTD): An Effective Combination for Relapsed/Refractory Multiple Myeloma Failing Thalidomide and Dexamethasone.

Free
Evren Ozdemir, MD, Yener Koc, MD, Ayse Kars, MD, Alev Turker, MD, Gulten Tekuzman, MD, Emin Kansu, MD
Journal: Blood
Blood (2007) 110 (11): 4810.
https://doi.org/10.1182/blood.V110.11.4810.4810
Published: 2007